Keyphrases
Bone Turnover Markers
100%
Bone Mineral Density
90%
P2X7 Receptor (P2X7R)
62%
Procollagen Type 1 N-terminal Propeptide (P1NP)
58%
Osteoporosis
57%
Bone Turnover
39%
Osteocalcin
38%
Bone Resorption
37%
Randomized Controlled Trial
34%
Fracture Risk
31%
Bone Loss
31%
Bone Formation
30%
Bone Metabolism
29%
Intact Parathyroid Hormone (iPTH)
25%
Bone Health
24%
Placebo
23%
Osteoclast
22%
Type 2 Diabetic Patients
22%
Type 2 Diabetes Mellitus (T2DM)
21%
Postmenopausal Women
21%
Polymorphism
20%
Peripheral Quantitative Computed Tomography (pQCT)
20%
Osteoblast
20%
Bone Mass
20%
Blood Samples
19%
Bone Microarchitecture
19%
Randomized Placebo-controlled Trial
18%
Body Composition
17%
Clopidogrel
17%
Sclerostin
16%
Receptor Gene
16%
Denmark
16%
Type 1 Diabetes Mellitus (T1DM)
15%
Glucagon-like
15%
Single nucleotide Polymorphism
15%
Meta-analysis
14%
Bone Alkaline Phosphatase
14%
Patients with Epilepsy
14%
Calcium Signaling
14%
C-terminal Telopeptide of Type I Collagen
14%
Antiresorptive
13%
Bone Remodeling
13%
Knock-in Mouse Model
13%
Lumbar Spine
13%
P2 Receptors
13%
Tibia
13%
Dual-energy X-ray Absorptiometry
13%
Calcitonin Gene-related Peptide
13%
Whole-body Vibration Training
13%
Metabolic Bone Disease
13%
Medicine and Dentistry
Bone Turnover
79%
Bone Density
60%
Osteolysis
42%
Placebo
32%
Osteoporosis
30%
Procollagen
29%
Ossification
28%
Osteocalcin
27%
Amino Terminal Sequence
27%
Biological Marker
24%
Osteoblast
22%
Purinergic P2X7 Receptor
21%
Maturity Onset Diabetes of the Young
20%
Bone Strength
19%
Disease
18%
Randomized Controlled Trial
18%
Tibia
17%
Calcium Signaling
17%
Diabetes
16%
Isotopes of Calcium
16%
Bone Mass
15%
Sclerostin
13%
Bone Metabolism
13%
Hip
13%
Collagen Type 1
13%
Osteoclast
13%
Patient with Type 2 Diabetes
13%
Cross Sectional Study
12%
Glucagon-Like Peptide-1 Agonist
12%
Quantitative Computed Tomography
12%
Bone Mineral
11%
Muscle Strength
11%
Dual-Energy X-Ray Absorptiometry
11%
Cardiovascular System
11%
Biochemical Marker
11%
Breast Cancer
10%
Insulin Dependent Diabetes Mellitus
10%
Roux-en-Y Gastric Bypass
10%
Hip Fracture
10%
Gap Junction
10%
Adenosine Triphosphate
10%
Patient with Epilepsy
9%
Body Mass Index
9%
Parathyroid Hormone
9%
Osteoplasty
9%
Receptor
9%
Supplementation
9%
Exercise
8%
Denosumab
8%
Lumbar Spine
8%